In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
All, At the Moscow Ministerial Meeting on TB, WHO released a policy brief that aims to articulate a coherent vision of the research needs to end TB and elaborates on the funding and structural requirements that are necessary to operationalize this vision. URL: http://www.who.int/tb/publications/2017/Global_Investments_in_Tuberculosis_Research_Investment/en/ Also see this related blog post ... read more
If you are directly or indirectly involved in the care of people with multidrug-resistant TB (MDR-TB), please consider endorsing this pledge to empower people with MDR-TB to choose between the use of a novel drug (currently bedaquiline or delamanid) or an injectable aminoglycoside drug as part of their MDR-TB regimen, ... read more
Many thanks for this information read more
Sagam Community HospitalWork Locations
DNA Genotek Inc.Work Locations
National Academy of Medical SciencesWork Locations